1-3 of 3
Igor Koltunov, MD PhD
Close
Sort by
Journal Articles

Prophylactic Treatment with New Recombinant Factor IX Innonafactor (Russia) in Adolescent and Adult Patients with Hemophilia B

Ekaterina Shiller, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artyom Bullih, Michael A Maschan, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4895.
https://doi.org/10.1182/blood.V130.Suppl_1.4895.4895
Published: 2017
Journal Articles

Long-Term Prophylaxis with Activated Recombinant FVII in Children with Hemophilia a and Inhibitor, Receiving Treatment with ITI Protocol

Ekaterina Shiller, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Vladimir Vdovin, MD, Igor Koltunov, MD PhD, Artem Bullikh, MD, Eugene Nikitin, MD PhD, Dmitry Kudlay, MD PhD Prof., Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4980.
https://doi.org/10.1182/blood.V128.22.4980.4980
Published: 2016
Journal Articles

Safety and Efficacy of New Moroctocog Alfa Drug (Octofactor) in Prophylactic Treatment in Adolescent Patients with Severe and Moderate Hemophilia a

Ekaterina Shiller, MD, Vladimir Vdovin, MD, Victor Petrov, MD PhD, Pavel Svirin, MD, Tatiana Andreeva, MD PhD, Inna Lavrichenko, MD, Artem Bullikh, MD, Igor Koltunov, MD PhD, Igor Davydkin, Prof., Igor Kurtov, MD PhD, Alexandr Shuster, Academician, PhD, Dmitry Kudlay, MD PhD Prof., Sergey Lukyanov, MD PhD, Anton Borozinets, MD PhD, Eugene Nikitin, MD PhD, Ekaterina Klykova, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4703.
https://doi.org/10.1182/blood.V126.23.4703.4703
Published: 2015